| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyell Immunopharma, Inc. | Director | Common Stock | 200,000 | $94,000 | $0.4700 | 15 May 2025 | Grantor and Trustee |
| Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130,000 | 15 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | 15 May 2025 | 1 | $0 | 4 | Director | 19 May 2025, 18:41 |
| LYEL | Lyell Immunopharma, Inc. | 21 Mar 2025 | 1 | +$115,220 | 4 | Director | 25 Mar 2025, 18:46 |
| LYEL | Lyell Immunopharma, Inc. | 31 Oct 2024 | 1 | $0 | 4 | Director | 01 Nov 2024, 16:56 |
| LYEL | Lyell Immunopharma, Inc. | 31 Oct 2024 | 0 | $0 | 3 | Director | 01 Nov 2024, 16:54 |